ORGANON'S ORGARAN FOR PREVENTION OF DEEP VENOUS THROMBOSIS IN ELECTIVE HIP SURGERY SHOWS SUPERIORITY TO WARFARIN IN COMPARATIVE TRIAL -- LABELING
Executive Summary
Organon's Orgaran (danaparoid sodium) shows significant superiority to warfarin in preventing deep venous thrombosis in patients undergoing elective hip replacement, according to the results of a 396-patient comparative trial reported in approved product labeling.